These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34041632)

  • 21. Enhancing percutaneous delivery of methotrexate using different types of surfactants.
    Javadzadeh Y; Hamishehkar H
    Colloids Surf B Biointerfaces; 2011 Feb; 82(2):422-6. PubMed ID: 20951009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
    Shaif M; Kushwaha P; Usmani S; Pandey S
    J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming barriers by local drug delivery with liposomes.
    Antimisiaris SG; Marazioti A; Kannavou M; Natsaridis E; Gkartziou F; Kogkos G; Mourtas S
    Adv Drug Deliv Rev; 2021 Jul; 174():53-86. PubMed ID: 33539852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis.
    Tripathi P; Kumar A; Jain PK; Patel JR
    Int J Biol Macromol; 2018 Dec; 120(Pt A):1322-1334. PubMed ID: 30171962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the prospective of nano-formulations towards the treatment of psoriasis.
    Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin
    Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
    Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
    Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
    Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
    Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
    [No Abstract]   [Full Text] [Related]  

  • 28. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review.
    Bahadur S; Sharma M
    Curr Pharm Biotechnol; 2023; 24(11):1383-1396. PubMed ID: 36518042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis.
    Wadhwa S; Singh B; Sharma G; Raza K; Katare OP
    Drug Deliv; 2016 May; 23(4):1204-13. PubMed ID: 26592918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal treatment of psoriasis.
    Nayak N; Somanna P; Patil AB; Radhakrishnan A
    Ther Deliv; 2020 Dec; 11(12):807-819. PubMed ID: 33267650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.
    Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R
    J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
    Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
    Drug Deliv; 2020 Dec; 27(1):662-680. PubMed ID: 32393082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, characterization and optimization of methotrexate-olive oil nano-emulsion for topical application.
    Rashid SA; Bashir S; Ullah H; Shah KU; Khan DH; Shah PA; Danish MZ; Khan MH; Mahmood S; Sohaib M; Irfan MM; Amin A
    Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):205-215. PubMed ID: 34275844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A; Goyal AK; Kesarla R; Murthy RR
    J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
    Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
    J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.
    Zeb A; Qureshi OS; Kim HS; Cha JH; Kim HS; Kim JK
    Int J Nanomedicine; 2016; 11():3813-24. PubMed ID: 27540293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and In Vivo Evaluation of Rosmarinic Acid-Loaded Transethosomes After Percutaneous Application on a Psoriasis Animal Model.
    Rodríguez-Luna A; Talero E; Ávila-Román J; Romero AMF; Rabasco AM; Motilva V; González-Rodríguez ML
    AAPS PharmSciTech; 2021 Mar; 22(3):103. PubMed ID: 33712964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices.
    Ramanunny AK; Wadhwa S; Gulati M; Singh SK; Kapoor B; Dureja H; Chellappan DK; Anand K; Dua K; Khursheed R; Awasthi A; Kumar R; Kaur J; Corrie L; Pandey NK
    Eur J Pharmacol; 2021 Jan; 890():173691. PubMed ID: 33129787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elastic liposomes as novel carriers: recent advances in drug delivery.
    Hussain A; Singh S; Sharma D; Webster TJ; Shafaat K; Faruk A
    Int J Nanomedicine; 2017; 12():5087-5108. PubMed ID: 28761343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.